ARCHIVES

Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma

This article is from The Cancer Letter archive.

Vol. 40 No. 33 | September 5, 2014

Download PDF Visit The Full Archive

Related Articles

Taxol Plus Carboplatin Increased Survival Of NSCLC In Patients 70 And Older

June 25, 2010

Five Year Plan for Cancer centers Called ‘East Bloc ’ Directive

February 2, 1990

Van Potter Wins Bristol-Myers Award

April 24, 1981

Two-Month Survival Benefit For Some NSCLC Patients

May 31, 2002

Meta-Analysis Finds ESA Use In Oncology Associated With Increases In VTE, Mortality.

February 29, 2008

In Brief: Healy Nominated to Head NIH; Hammond, D’Angio To Step Down as Group Chairman

January 18, 1991